Skip to main content
Log in

Bile Salt–Fatty Acid Mixed Micelles as Nasal Absorption Promoters of Peptides. II. In Vivo Nasal Absorption of Insulin in Rats and Effects of Mixed Micelles on the Morphological Integrity of the Nasal Mucosa

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

The effectiveness of mixed micelles in promoting nasal absorption of peptides has been demonstrated in vivo by employing insulin as a model compound. Insulin in the absence of adjuvants was not absorbed following intranasal administration. The results confirmed previous findings by others that absorption of insulin via alternative routes required absorption enhancers. Mixed micelles between NaGC and linoleic acid were found to rapidly deliver insulin into systemic circulation, with a concomitant decrease in plasma glucose. The extent of the hypoglycemic response was significantly greater than that produced by NaGC alone (55 vs 47%, P < 0.05). Emulsion of linoleic acid, on the other hand, did not produce any significant insulin absorption. The findings thus supported previous in situ data that mixed micelles were more effective than NaGC or linoleic acid in promoting nasal absorption of peptides. Histopathologic examination of the rat nasal mucosa revealed that the extent of morphological alterations caused by mixed micelles was of mild to moderate severity even after 5 hr of exposure. However, studies involving more frequent and prolonged exposures are necessary to assess the practicality of these adjuvants before any clinical application can be attempted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. P. Tengamnuay and A. K. Mitra. Pharm. Res 7:127–133 (1990).

    Google Scholar 

  2. B. J. Aungst, N. J. Rogers, and E. Shefter. J. Pharmacol. Exp. Ther. 244:23–27 (1988).

    Google Scholar 

  3. G. S. Gordon, A. C. Moses, R. D. Silver, J. S. Flier, and M. C. Carey. Proc. Natl. Acad. Sci. 82:7419–7423 (1985).

    Google Scholar 

  4. A. C. Moses, G. S. Gordon, M. C. Carey, and J. S. Flier. Diabetes 32:1040–1047 (1983).

    Google Scholar 

  5. A. E. Pontiroli, M. Alberetto, A. Calderara, E. Pajetta, and G. Pozza. In S. S. Davis, L. Illum, and E. Tomlinson (eds.), Delivery Systems for Peptide Drugs, Plenum Press, New York, 1986, pp. 243–248.

    Google Scholar 

  6. S. Hirai, T. Ikenaga, and T. Matsuzawa. Diabetes 27:296–299 (1978).

    Google Scholar 

  7. S. Hirai, Y. Takatsuka, and H. Mima. Int. J. Pharm. 9:165–172 (1981).

    Google Scholar 

  8. S. Hirai, Y. Takatsuka, and H. Mima. Int. J. Pharm. 9:173–184 (1981).

    Google Scholar 

  9. G. S. M. J. E. Duchateau, J. Zuidema, and F. W. H. M. Merkus. Int. J. Pharm. 31:193–199 (1986).

    Google Scholar 

  10. S. J. Hersey and R. T. Jackson. J. Pharm. Sci. 76:876–879 (1987).

    Google Scholar 

  11. A. L. Daugherty, H. D. Liggitt, J. G. McCabe, J. A. Moore, and J. S. Patton. Int. J. Pharm. 45:197–206 (1988).

    Google Scholar 

  12. S. Hirai, Y. Takatsuka, T. Matsuzawa, and H. Mima. Int. J. Pharm. 7:317–325 (1981).

    Google Scholar 

  13. J. T. Young. Fund. Appl. Toxicol. 1:309–312 (1981).

    Google Scholar 

  14. J. Radziuk and T. Morishima. Adv. Exp. Med. Biol. 189:247–276 (1985).

    Google Scholar 

  15. W. A. Lee, R. A. Ennis, and L. C. Foster. Proc. Int. Symp. Control. Rel. Bioact. Mater. 15:70–71 (1988).

    Google Scholar 

  16. L. L. Bellinger and V. E. Mendel. Proc. Soc. Exp. Biol. Med. 148:5–8 (1975).

    Google Scholar 

  17. N. Muranushi, M. Kinugawa, Y. Nakajima, S. Muranishi, and H. Sezaki. Int. J. Pharm. 4:271–279 (1980).

    Google Scholar 

  18. N. Muranushi, Y. Nakajima, M. Kinugawa, S. Muranishi, and H. Sezaki. Int. J. Pharm. 4:281–290 (1980).

    Google Scholar 

  19. S. Feldman and M. Gibaldi. Proc. Soc. Exp. Biol. Med. 132:1031–1033 (1969).

    Google Scholar 

  20. J. P. Longenecker. In S. S. Davis, L. Illum, and E. Tomlinson (eds.), Delivery Systems for Peptide Drugs, Plenum Press, New York, 1986, pp. 211–220.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tengamnuay, P., Mitra, A.K. Bile Salt–Fatty Acid Mixed Micelles as Nasal Absorption Promoters of Peptides. II. In Vivo Nasal Absorption of Insulin in Rats and Effects of Mixed Micelles on the Morphological Integrity of the Nasal Mucosa. Pharm Res 7, 370–375 (1990). https://doi.org/10.1023/A:1015867305641

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015867305641

Navigation